Table 2.

Reported components of the FLS patients’ phenotype

Author	Age (mean)	Men (%)	Fracture location (%)			BMI (mean)
			Hip	Clinical VF	NV/NH
IP+OP, F+M, 50+, all Fx
McLellan [13]
Blonk [19]	64	24	9	5	86	27
Eekman [20]	68	22
Fraser [21]	70	14	8	10	82
Malgo [22]	67	27	9	6	85
Naranjo [23]	71	23	22	6	72
Naranjo [24]	72	22	26
Ojeda [25]	70	13	19	8	73	29
Woltman [26]	73	21	23	2	75
Ong [27]	66	17
Van den Berg [28]		20
Huntjens [29]	67	23	6
Bours [30]		23
De Klerk [31]	67	21	8	13	79	28
De Klerk [32]	66	22
Hegeman [33]	67	26	11	3	86	25
Wyers [34]	65	28	8			26
Van Helden [35]	67	28	13	3	84
Range	64–73	13–28	6–26	2–13	72–86	25–29
IP+OP, F+M, 50+, NVF
Gallacher [39]		23	5	Excl.	95	24
Howat [40]		21	13	Excl.	87
Huntjens [42]	67	27		Excl.
Range	67	21–27	5–13	Excl.	87–95	24
IP+OP, F+M, all Fx, various ages
Langridge [37]	78		28
Ahmed [43]		19	2	3	95
Abbad [44]	80	21	45
Miscellaneous
Van Helden [36]	67	28
Dumitrescu [38]	68	27	17	4	79
Gallacher [41]	66	24	26	Excl.	74
Premaor [45]		Excl.	6	<1	94	27
Premaor [46]		Excl.	10	<1	90	27
Dehamchia [47]	67	25	28
Nassar [48]	74	13	51	Excl.	49	24
Ganda [49]	65	20
Beringer [50]	65	30	Excl.	41	59
Range overall	64–80	13–30	2–51	<1–41	49–95	24–29